31 results
8-K
EX-10.1
AGRX
Agile Therapeutics Inc
28 Sep 23
Entry into a Material Definitive Agreement
4:50pm
standard identifiers SLN, NPI, DEA #s for initial and ongoing data validation.
(3)Usage of data hygiene scrub – for HCP demographic data
8-K
EX-99.1
4vs8wsin
7 Nov 22
Agile Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
4:10pm
8-K
EX-99.1
o4a974gnega 5o8p
11 Aug 22
Agile Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
4:10pm
8-K
EX-99.1
vgr7y1a 5v0
12 May 22
Agile Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update
4:10pm
8-K
EX-1.1
cmrxdudx0q0je0vq5 mb
27 Apr 22
Agile Therapeutics Announces 1-FOR-40 Reverse Stock Split
7:21am
8-K
EX-99.1
8fgrqn77o1khea3v
30 Mar 22
Agile Therapeutics Reports Fourth Quarter & Full Year 2021 Financial Results and Provides Corporate Update
4:19pm
8-K
EX-1.1
26ul3
10 Jan 22
Entry into a Material Definitive Agreement
8:05am
8-K
EX-1.1
jlzj8ujy
18 Mar 21
Entry into a Material Definitive Agreement
5:13pm